The Iliac/SFA/Popliteal Center

Filter Your Results




Interim BIOFLEX PEACE Data Presented for Biotronik’s Pulsar-18 Stent in SFA Treatment

November 23, 2016 -- Biotronik announced that interim data from the BIOFLEX PEACE all-comers trial, which confirm the efficacy of the company’s Pulsar-18 bare-metal, sel…

Spectranetics’ Stellarex 0.014-Inch DCB Approved in Europe

November 21, 2016 -- The Spectranetics Corporation announced that the company’s Stellarex 0.014-inch drug-coated balloon (DCB) has received European CE Mark approval. …

Financing Will Advance Development of Shockwave Medical’s Lithoplasty Treatment

November 22, 2016 -- Shockwave Medical, a developer of treatments for calcified cardiovascular disease, announced the closing of $45 million in Series C financing led by Secto…

Understanding Clinical Data and Its Application to Clinical Practice

Krishna Rocha-Singh, MD

November 2016—The emphasis on evidence-based medical practice emerged in response to the potential hazards and inconsistencies of empirical clinical decision making and reinforced the impor…

FIH Study Begins for Med Alliance’s Selution Sirolimus-Coated Balloon

November 10, 2016 -- Switzerland-based Med Alliance recently announced commencement of patient enrollment in the first-in-human (FIH) study of the Selution sirolimus-coated ba…

Global DISRUPT PAD III Trial Will Evaluate Shockwave Medical’s Lithoplasty System Combined With DCB Therapy in Calcified PAD

November 1, 2016 -- Shockwave Medical announced plans for the DISRUPT PAD III multicenter randomized trial that will exclusively enroll patients with calcified peripheral arte…

SoundBite Medical Solutions Announces New Funding for CTO Technology

October 31, 2016 -- SoundBite Medical Solutions Inc. (SBMS), a Quebec-based cardiovascular medical technology company, announced the third closing of a seed equity r…

ILLUMENATE Pivotal Trial Results Presented for Spectranetics’ Stellarex Drug-Coated Balloon

November 2, 2016 -- The Spectranetics Corporation announced that the final 12-month results of the ILLUMENATE pivotal trial for the company’s Stellarex drug-coated …




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.